Showing posts with label shareholders. Show all posts
Showing posts with label shareholders. Show all posts

Thursday, November 21, 2019

Why Business Leaders Need to Understand Their Algorithms; Harvard Business Review, November 19, 2019

Mike Walsh, Harvard Business Review; Why Business Leaders Need to Understand Their Algorithms

"Leaders will be challenged by shareholders, customers, and regulators on what they optimize for. There will be lawsuits that require you to reveal the human decisions behind the design of your AI systems, what ethical and social concerns you took into account, the origins and methods by which you procured your training data, and how well you monitored the results of those systems for traces of bias or discrimination. Document your decisions carefully and make sure you understand, or at the very least trust, the algorithmic processes at the heart of your business.

Simply arguing that your AI platform was a black box that no one understood is unlikely to be a successful legal defense in the 21st century. It will be about as convincing as “the algorithm made me do it.”"

Wednesday, December 5, 2018

CBS Report on Moonves Shows Epic Failure of Corporate Governance; The New York Times, December 4, 2018

James B. Stewart, The New York Times; CBS Report on Moonves Shows Epic Failure of Corporate Governance

[Kip Currier: Another example of toxic organizational culture--at multiple levels--that's also a "teachable moment" case study on the need for ethical leadership.

It's also (another) call for action and responsibility by Board members in all kinds of organizations--for profit and non-profit:

If you see (or reasonably suspect) something illicit, illegal, or unethical is occurring within your organization, say something!

You have an ethical duty to act. Not to cover up, turn away your gaze, or enable.

Ask tough questions. Demand answers. Report concerns and observations to outside parties when you can't get answers or information from within.

Do your duty. Do the right thing.

Even if it's hard.]

"As a draft report prepared by CBS’s outside lawyers now makes clear, many of the company’s employees, including high-ranking executives and even members of its board, were aware of the former chief executive Leslie Moonves’s alleged sexual misconduct and subsequent efforts to conceal it.

Yet no one acted to stop him — and the repercussions for that failure are likely to reverberate at CBS for years.

“A culture where this behavior could have gone unchecked for so long with so much knowledge is really troubling,” said Charles M. Elson, an expert on corporate governance at the University of Delaware. “This is a disaster for CBS shareholders. There’s been no other #MeToo incident with this kind of negative impact” on a major American company...

Members of corporate boards, senior executives and even rank-and-file employees have a duty of loyalty — to the company, not its chief executive. They’re required by corporate law, company policy and in many cases their employment contracts to report misconduct to the board."

Sunday, March 4, 2018

What price privacy when Apple gets into bed with China?; Guardian, March 4, 2018

John Naughton, Guardian; What price privacy when Apple gets into bed with China?

"Corporations can blather on all they like about corporate responsibility and human rights, but, in the end, maximising shareholder value is all that counts. And Apple is determined to get to that trillion-dollar valuation no matter what. So if you’re an Apple user in China, you now have a simple choice: junk your iPhone, iPad and fancy Macbook laptop; or accept that your autocratic rulers can access your data at their convenience. In which case, whatever you say, say nothing – as they used to say in Belfast."

Tuesday, August 23, 2016

U.S. lawmakers demand investigation of $100 price hike of lifesaving EpiPens; Washington Post, 8/23/16

Ariana Eunjung Cha, Washington Post; U.S. lawmakers demand investigation of $100 price hike of lifesaving EpiPens:
"The medication itself isn’t expensive. Analysts calculate that the dosage contained in a single pen is worth about $1. It’s the company’s proprietary pen injector that makes up the bulk of the cost...
A profile in Fortune in 2015 described her rise in colorful terms:
Bresch, a 46-year-old who’s spent more than half her life at Mylan, has steered the company’s transformation from a quirky outfit run out of a West Virginia trailer to a global operator with 30,000 employees in 145 countries. Born into politics—her father, Joe Manchin, is a longtime West Virginia Democratic stalwart who’s now a U.S. senator—Bresch has mastered the regulatory world. Since becoming CEO in 2012, she’s overseen a major revenue increase; Mylan projects sales of up to $10.1 billion this year, up from $6.1 billion in 2011…
Under Bresch’s leadership, Mylan has also stumbled through a series of ethically messy mishaps and public relations gaffes. Mylan’s inversion took place just as uproar over the tactic reached a fever pitch on Capitol Hill. (Among the politicians who denounced the move was Bresch’s own father, though he later changed his mind.) Critics have called out the company for unusually high executive pay packages, questionable use of company jets, and murky relationships with board members. Then there’s “the Heather Bresch situation,” as she herself calls it, a scandal surrounding her executive MBA credentials—when you Google her name, the episode still ranks even higher than her official Mylan bio."